Consolidated Statement of Cash Flows (Unaudited) - USD ($)	3 Months Ended		9 Months Ended
	Sep. 30, 2023	Sep. 30, 2022	Sep. 30, 2023	Sep. 30, 2022
CASH FLOWS FROM OPERATING ACTIVITIES:
Net loss	$ (12,589,572)	$ (5,681,574)	$ (24,068,576)	$ (16,234,682)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization			781,852	442,890
Stock-based compensation			731,768	923,844
Change in FV-Derivative Liability	(3,216,000)		(3,216,000)
Change in FV-Warrant Liability	10,095,960		10,095,960
Amortization of right-of-use asset			123,885	155,308
Bad debt expense		2,136	292,010	2,136
Unrealized gain on marketable securities	(403,996)	32,135	(602,211)	75,204
Realized gain on marketable securities	(90,812)	(103,000)	(143,344)	(110,490)
Impairment of inventory and prepaid				2,351,947
Change in operating assets and liabilities:
Accounts receivable			74,072	510,922
Inventory			(3,376,229)	462,025
Prepaid expenses and other current assets			(1,606,457)	(1,430,565)
Deposits and other assets			(500)	18,798
Accounts payable			(280,291)	516,347
Accrued expenses			28,029	(473,953)
Lease obligations - operating leases			(136,086)	(168,935)
Net cash used in operating activities			(21,302,119)	(12,959,204)
CASH FLOWS FROM INVESTING ACTIVITIES:
Purchase of property and equipment			(2,076,070)	(970,557)
Change in marketable securities			(24,033,422)	(15,755,310)
Purchase of intangible assets			(29,204)	(46,546)
Net cash used in by investing activities			(26,138,696)	(16,772,413)
CASH FLOWS FROM FINANCING ACTIVITIES:
Proceeds from private placement of preferred stock, net of transaction costs			21,632,156
Net cash provided by financing activities			21,632,156
Net change in cash, cash equivalents and restricted cash			(25,808,660)	(29,731,616)
Cash, cash equivalents and restricted cash, beginning of period			39,096,562	69,160,466
Cash, cash equivalents and restricted cash, end of period	13,287,902	39,428,850	13,287,902	39,428,850
Supplemental disclosure of cash and non-cash transactions:
Accrual of Series H-7 Convertible Preferred Stock Dividends			244,000
Restricted Stock issued previously accrued				329,381
Initial fair value of warrant liability			9,969,480
Initial fair value of derivative liability			5,147,000
Deemed Dividend H-5 Warrants			199,000
Accretion of discounts to redemption value of H-7 convertible preferred stock	1,165,635		1,165,635
Accrued fixed assets				193,053
Supplemental disclosure of restricted cash:
Cash and cash equivalents	3,287,902	39,428,850	3,287,902	39,428,850
Restricted Cash	10,000,000		10,000,000
Total cash, cash equivalents and restricted cash	$ 13,287,902	$ 39,428,850	$ 13,287,902	$ 39,428,850